Ca 2+ -binding proteins (CaBP) alter Ca 2+ signals, triggering cellular processes such as gene transcription regulation in neurons. CaBP1/CD is a calmodulin (CaM)-like Ca 2+ binding protein that may regulate neuronal functions through interactions with effectors such as voltage-gated Ca 2+ (Ca v ) channels and inositol trisphosphate receptors (InsP 3 Rs). To gain insight into the potential cellular functions of CaBP1/CD, we analyzed the expression and localization of CaBP1/CD variants in mouse brain. Of the three CaBP1/CD splice variants that have been characterized (CaBP1-S, CaBP1-L, and caldendrin (CD)), CD was the major variant expressed in mouse brain by western blot and quantitative polymerase chain reaction. These results reflected the expression of CaBP1/CD since they were not reproduced in mice with targeted disruption of the gene encoding CaBP1/CD (CaBP1 knock-out). By immunoperoxidase labeling, CaBP1/CD was localized in multiple cell-types including pyramidal cells in the cerebral cortex and hippocampal CA3 neurons and inhibitory neurons in the cerebellum. In the cerebellum, CaBP1/CD was not detected in Purkinje neurons but strongly colocalized with voltage-sensitive Shaker-type potassium channel, K v 1.2, in the pinceau formation formed between basket cells and the Purkinje cell axon initial segment. We conclude that CaBP1/CD is expressed in a subset of principal neurons where it may regulate Ca 2+ signaling and neuronal excitability.
. Upon binding to Ca 2+ ions, CaM undergoes a conformational change, exposing its hydrophobic binding sites Meyer et al., 1996) . CaM interacts with and regulates numerous kinases, ion channels, and other effectors, triggering many essential cellular events.
Ca 2+ -Binding Protein 1 (CaBP1/CD) belongs to a family of EF-hand Ca 2+ binding proteins that is abundantly expressed in the brain and retina , but the physiological role of CaBP1/CD remains unclear. Similar to CaM, CaBP1/CD has four EF-hand motifs (EF-hand 1-4), but only three are functional (EF-hand 1, 3-4). Ca 2+ cannot bind to EF-hand 2, which further inhibits cooperative Ca 2+ binding to EF-hand 1 (Wingard et al., 2005) . Compared to CaM, the central linker domain in CaBP1/CD is extended by one α-helical turn, which may significantly affect CaBP1/CD interactions with effectors .
Three splice variants of CaBP1/CD exist that vary in length and their N-terminal regions Laube et al., 2002) . Sequence alignments ( Fig. 2A ) revealed unique properties of these isoforms. CaBP1-S (short), CaBP1-L (long) and caldendrin (CD) share identical EF-hand organization while their N-terminal regions differ in length and structure.
CaBP1-S and CaBP1-L contain an N-myristoylation site, which may be critical for its distinct localization in transfected CHO cells , whereas CD lacks this feature (Mikhaylova et al., 2006) .
CaM and CaBP1/CD bind to the same target proteins like voltage-gated Ca 2+ (Ca v ) channels, but CaBP1/ CD often has distinct modulatory properties compared to CaM Lee et al., 2002; Yang et al., 2002; Zhou et al., 2004; Zhou et al., 2005) . While CaM increases Ca 2+ -dependent inactivation (CDI) of L-type Ca 2+ (Ca v 1) channels, CaBP1/CD inhibits CDI Yang et al., 2006; Zhou et al., 2004 To broaden our understanding of CaBP1 and CD role in the central nervous system, we analyzed the expression and localization of CaBP1/CD in mouse forebrain and cerebellum, and generated a CaBP1 knockout (KO) mouse. Consistent with previous findings, we observed CaBP1/CD labeling using CaBP1/CD antibodies in neurons throughout the brain, including in a subset of neurons in the hippocampus and cerebral cortex. Expanding from previous reports, we performed double immunofluorescence labeling and discovered localization of CaBP1/CD variants in presynaptic and postsynaptic compartments of GABA-ergic inhibitory interneurons.
We also analyzed the expression of CaBP1 splice variants by quantitative PCR, and demonstrate CD as the major CaBP1/CD variant expressed in the mouse brain. Additionally, we
show that the two variants of CD detected in the brain (33-/36-kDa), may result from alternative translation start sites. We conclude that CaBP1/ CD localizes in a subpopulation of excitatory and inhibitory neurons, where CD potentially modulates Ca 2+ -dependent processes important for neuronal physiology.
CHAPTER II.
MATERIALS AND METHODS

Animals
Animal handling was approved by the University of Iowa Institutional Animal Care and Use Committee, and used in accordance with the National Institutes of Health guidelines. Forty-six genetically modified adult mice (2-5 months old, F2 generation) from a 129/SvEv and C57Bl6 mixed strain were used for immunohistochemistry, molecular biology, and biochemical analysis.
Construction of CaBP1/CD Targeting Vector
In order to generate a CaBP1/CD-deficient mouse, a targeting vector was constructed. An insertion of a 2.4 kilobase (kb) upstream of exon 1a, and a 5.8 kb fragment found downstream of exon 1b were amplified by PCR. The 2.4 kb insert was ligated into the targeting vector before an mCherry start site using NotI/NheI, and the 5.8 kb fragment was added downstream of a neomycin sequence (SalI). The final CaBP1/CD targeting construct was sent to the University of Iowa Gene Transfer Core Facility.
Generation of CaBP1/CD-deficient Mice
Embryonic stem cells (ES) from 129/SvEv strain were electroporated with the CaBP1/CD targeting vector at the University of Iowa Gene Transfer Core. Seven positive recombinant ES cells that were neomycin-resistant and expressed an mCherry sequence, assessed by polymerase chain reaction (PCR) (oAL676 forward 5'-GTGTGCAAGATAACCAGCTTC-'3; oAL655 reverse 5'-CATGGTCTTCTTCTGCATTAC-3'), were injected into host C57/Bl6 mouse blastocysts at the University of Iowa Gene Transfer Core Facility. Once chimeras were generated, they were crossed with C57/Bl6 mice in order to transmit the CaBP1/CD mutant gene into germ-line. Genomic DNA was extracted from pups, and the presence of the mutant allele was confirmed by genotyping.
Littermates carrying the mutant allele were mated to produce CaBP1 KO mice. The CaBP1 knockout was further validated by RT-PCR, immunoblotting and immunohistochemistry.
Genotyping
Genomic DNA was isolated from fresh mouse tissue. Fragments of the wild-type (WT) and knockout (KO) alleles were amplified by PCR using GoTaq Green Master Mix (Promega, Madison, WI) and 300 nanograms (ng) of genomic DNA. The following oligos primers were used in the PCR reaction: (oAL795 WT for. 5'-CTCGTGCTCACATTCAGTGC-3'; oAL796 WT rev.
5'-CAATGTGCGAGCTCATCG-3'; oAL797 KO rev. 5'-GATGATGGCCATGTTATCCTC-3').
PCR products were viewed under an ultraviolet transilluminator.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from mouse brain tissue using TRIzol reagent (Life Technologies, Grand Island, NY). Brain cDNAs were synthesized using oligo (dT) primers from the Two-step Superscript III Kit (Life Technologies). By PCR methods, the expression of each variant was detected using isoform-specific primers (GAPDH for. 5'-CCTCTGGAAAGCTGTGGCGTGATGG-3'; rev. 5'-AGATCCACGACGGACACATT-3';
oAL701 CaBP1-S and -L for. 5'-CAAGTCGCCACTAAGAAACC-3'; oAL702 CD rev. 5'-CGGACCCGTTCCTCCAC-3'; oAL703 CaBP1/CD rev. 5'-GTTGATCTGCTGAGACAGCTC- to 2A (Fig. 1A ). GAPDH was used as an endogenous normalizer. These assays were tested against CaBP1 and CD plasmid DNAs to verify the specificity of the assay for the intended target. Assays were also tested on serial dilutions of cDNA prepared from total brain RNA to verify that CD, possible RQ values calculated from a 95% confidence interval of C T values.
CD Short and Long (CD-S AND -L) Isolation
Designed to isolate CD-S and CD-L fragments in WT mouse brain, CD-specific primers amplified each fragment using the following primers: oAL798 CD-S forward 5'-ATGAGCTCGCACATTGCC AAG-3'; oAL799 CD-L forward 5'-AGA GGCTGCGCTGTCACATG -3'; oAL800 common reverse 5'-TCAGCGAGACATCATCCGGAC-3'. PCR products were then ligated into pCR2.1TOPO vector (Life Technologies), excised, and inserted into CMV-promoter containing vector, pcDNA3.1+ (Life Technologies) using restriction sites EcoRI for CD-L and BamHI/XhoI for CD-S. The CD-S and -L constructs underwent sequencing analysis provided by the University of Iowa's DNA Sequencing Facility.
Antibodies
Polyclonal anti-CaBP1/CD rabbit antibodies were a generous gift from Dr. Françoise Haeseleer (Department of Ophthalmology, University of Washington School of Medicine, Seattle, Washington). Generated and purified from a bacterially expressed CaBP1-S protein (arrowheads, Fig. 2A ), these anti-CaBP1/CD antibodies recognize all variants. Specificity of the CaBP1/CD antiserum was confirmed by immunoblotting and immunohistochemistry using CaBP1/CD-null mice. A list of primary antibodies is provided in Table 1 .
Tissue Preparation
Adult CaBP1 WT, Het and KO mice were first exposed to isoflurane (Terrell, Bethlehem, PA), and then deeply anesthetized with a peritoneal injection of ketamine (50-100 mg/kg). Mouse 
Immunoperoxidase Labeling
Free-floating sections underwent immunoperoxidase staining following the standard 3,3'diamonibenzadine (DAB)/nickel immunperoxidase (Vectastain, Burlingame, CA) protocols in Tris-buffered saline (TBS). Sections were rinsed three times in TBS for 10 minutes each at room temperature before blocking endogenous peroxides with 0.3% hydrogen peroxide (H 2 O 2 ), and rinsed in TBS. Similar to our immunohistochemistry methods, sections were blocked in BB for 1 hour at 4°C, and submerged in BB containing primary antibodies (polyclonal anti-CaBP1/CD rabbit diluted to 1:15,000), and incubated overnight at 4°C. The following day, sections were washed three times in TBS for 10 minutes each followed by a secondary antibody incubation with donkey anti-rabbit biotinylated antibodies (1:400; Abcam, Cambridge, MA) for one hour at room temperature. Brain sections were rinsed three times in TBS for 10 minutes each.
Prior to adding DAB, sections were incubated with an avidin-biotin-peroxidase complex Technologies) . These polyacrylamide gels were run at 100 volts for 1.5-2 hours, and transferred onto a nitrocellulose membrane (BioRad, Hercules, CA) at 80 volts for 3 hours. Blots were blocked in 3-5 ml of 3% milk and TBST (0.1% Tween20 in TBS) for 1 hour at room temperature, and then incubated with primary polyclonal antibody, anti-CaBP1/CD (1:1000 for transfected HEK293T cell lysates and 1:4000 for brain fractions), for 1 hour at room temperature. After being rinsed three times in TBST, immunoblots were incubated with secondary antibody horseradish peroxidase anti-rabbit (1:4000; Jackson Immunoresearch) for 45 minutes at room temperature.
Blots were again rinsed three times with TBST before applying chemiluminescent substrates (Thermo Scientific), and exposed to an autoradiography film (Denville). 
RESULTS
Generation of CaBP1/CD-deficient Mice
We studied the expression and localization of CaBP1/CD in the mouse brain by RT-PCR and immunohistochemical methods, respectively. To ensure the specificity of our reagents for these experiments, we generated mice that lack expression of CaBP1/CD. We constructed a targeting construct which, upon homologous recombination of the inserted DNA sequence, would cause expression of a neomycin resistance gene and mCherry fluorescent protein in place of exon 1a and 1b of the mouse CaBP1/CD gene (Fig. 1A) . 129/SvEv embryonic stem (ES) cells were electroporated with this CaBP1/CD targeting construct and recombinant ES cells that were neomycin-resistant and contained the mCherry sequence were detected by PCR and microinjected into the blastocysts of wild-type C57/Bl6 mice. We confirmed the mutant allele had transferred into the germ-line of chimeric mice by PCR of genomic DNA (Fig. 1B-C) . We observed a 419 base pair (bp) PCR product corresponding to the mutant allele only in heterozygous and KO mice (+/-, CaBP1 Het; -/-, CaBP1 KO; Fig. 1B ). The WT allele (392 bp fragment from exon 1a) was detected in WT (+/+; CaBP1 WT) and heterozygous mice. These results indicated successful incorporation of the mutant allele by homologous recombination.
We further confirmed the disruption of CaBP1/CD expression in CaBP1 KO mouse by RT-PCR. cDNA was synthesized from isolated brain RNA of CaBP1 WT, Het and KO mice. To validate the specificity of the CaBP1 and CD primers, we used CaBP1 and CD plasmids, and observed the expected PCR product from each reaction (Fig. 1B) . The amplification of CaBP1/CD variants was only detected in WT and Het mice (Fig. 1C) . Despite the lack of CaBP1 PCR products in the KO lane, GAPDH products were amplified in WT, Het and KO mouse indicating that the total cDNA inputs were relatively the same. Taken together, these results show that CaBP1
KO mice lacked expression of CaBP1 and CD.
Comparison of CaBP1/CD Isoforms
CaBP1-L differs from CaBP1-S in that it possesses a 60-amino acid insertion (aa 16-75), which results in ~27 kDa protein product. CaBP1-S remains to be the smallest of the three isoforms with a molecular weight of ~19 kDa. CD, being the longest of the three isoforms, has an N-terminal region distinct from that of other CaBPs. Two protein products have been reported for CD (33 kDa (CD-S) and 36 kDa (CD-L)) (Seidenbecher et al., 1998) . In order to determine the relative protein levels of CaBP1 and CD, we probed for each isoform by immunoblotting methods using polyclonal anti-CaBP1/CD rabbit antibodies [UW72 ] generated against a sequence common to all variants (arrowheads, Fig. 2A ).
By western blotting, our CaBP1/CD antibody recognized all three variants in lysates of HEK293T cells transfected with each isoform (Fig. 2B) . These antibodies detected CD (especially CD-S) in the cytosol and membrane fractions of WT mouse brain (lanes 5 and 6; Fig. 2C ).
However, we did not detect CaBP1-S and -L proteins in either crude membrane or cytosol fractionations (Fig. 2C) . These results suggested that CD may be more highly expressed in the brain compared to CaBP1-S and -L.
To follow up on this possibility, we performed qRT-PCR assays using RNA isolated from three brain regions. Using CaBP1 and CD-specific probes designed by TaqMan (Life Technologies), the relative quantity (RQ) values of CaBP1/CD RNA levels were measured. Based on the RQ values, CD expression was higher in the cerebral cortex (Ctx) compared to the cerebellum (C) or hippocampus (Hc) (Fig. 3A) . CaBP1 was significantly greater in the cerebellum than the hippocampus (Fig. 3B) , but detected at much lower levels than CD in each brain region examined. Therefore, CD appears to be the dominant CaBP1/CD variant expressed in the brain at the transcript and protein level.
Previous studies suggest that the two variants of CD (CD-S and CD-L) are due to a conformational change induced by phosphorylation, which causes a shift in the electrophoretic mobility of the protein Seidenbecher et al., 1998) . However, there is a second methionine residue upstream of the methionine that would initiate translation of CD-S. Therefore the 36 kDa could correspond to a larger protein resulting from the upstream alternative site for translation (CD-L, Fig. 1A ). CD-L would include an additional 53 amino acids in its sequence compared to CD-S. To test this possibility, we generated cDNA expression constructs for mouse CD that would contain either of these translation start sites (CD-S and CD-L) and expressed them in HEK293T cells. By western blotting, the molecular weight of CD-L expressed in HEK293T cells (lane 4) was similar to the 36 kDa from mouse brain lysates (lanes 5-6; Fig. 2C ). This result suggests that the upstream alternate translation start site, rather than phosphorylation, could account for the larger protein detected by CaBP1/CD antibodies in mouse brain.
Distribution of CaBP1/CD Labeling in the Mouse Brain
To study the localization of CaBP1/CD in the murine brain, we performed immunoperoxidase labeling in coronal and sagittal brain sections from CaBP1 +/+ (wild-type) and +/-(heterozygous) mice. Throughout the brain, intense CaBP1/CD immunoreactivity (IR) was concentrated in brain regions with a laminar organization like the olfactory bulb, cerebral cortex, hippocampus or cerebellum (Fig. 4A ). Intense CaBP1/CD IR was also visualized in the brain stem and piriform cortex (Fig. 4A ). Immunoperoxidase labeling was specific in that it was observed in WT ( Fig. 4A ) but not CaBP1 KO brain sections (Fig. 4B ).
Distribution of CaBP1/CD varied along the rostral-caudal axis of the forebrain. In the cerebral cortex, strong CaBP1/CD IR was observed in principal cell bodies and dendrites in the piriform and somatosensory cortices ( Fig. 4C-D) . Furthermore, CaBP1/CD antibodies more strongly labeled somatosensory cortical layers II/III compared to layers V/VI (Fig. 4C-D, 5D ).
However, CaBP1/CD IR was generally consistent in intensity throughout the layers of the piriform cortex ( Fig. 4C-D) . In the hippocampus, we observed CaBP1/CD IR primarily in CA3 neurons ( Fig. 4C, 5A-B ), but very faint CaBP1/CD IR was found in CA1 and CA2 regions (arrow, Fig.   5A ). In contrast to the strong localization of other Ca 2+ binding proteins, such as parvalbumin and calbindin D-28k (Kawaguchi et al., 1995; Tepper and Bolam, 2004) , CaBP1/CD IR was very weak in the striatum.
We also examined the localization of CaBP1/CD in the substantia nigra. One of the known targets of CaBP1/CD, Ca v 1.3 Ca 2+ channels, is highly expressed in tyrosine hydroxylase (TH)expressing dopaminergic neurons in the substantia nigra pars compacta (SNc), where they may contribute to spontaneous neuronal firing and the progression of Parkinson's disease (Chan et al., 2007) . Double immunofluorescence labeling was performed on adult CaBP1 WT coronal brain sections using polyclonal anti-CaBP1/CD rabbit and monoclonal anti-TH mouse antibodies. THpositive cells (magenta) in the SNc were CaBP1/CD-negative ( Fig. 4E-G) . While these catecholaminergic cells lacked CaBP1/CD labeling in the SNc, CaBP1/CD (green) immunolocalized preferentially in substantia nigra pars reticulata (SNr) neurons where mainly PVpositive GABA-ergic neurons reside (Zhou and Lee, 2011) . These results show that within the substantia nigra, CaBP1/CD may regulate effectors in GABA-ergic neurons, but is not a likely modulator of Ca v 1.3 channels in dopaminergic neurons.
CaBP1/CD Labeling in the Hippocampus and Cerebral Cortex
Within the hippocampal formation, CaBP1/CD labeling was particularly intense in the CA3 region and in the hilus of dentate gyrus (DG) (Fig. 5A-C) . In the CA3 region, mainly pyramidal cell soma and dendrites were labeled, but some neurons scattered throughout the stratum oriens and radiatum also exhibited strong CaBP1/CD labeling (Fig. 5A-B ). To characterize these CaBP1/CD-positive cells using neurochemical markers, we performed double immunofluorescence labeling on adult CaBP1 WT mouse brain sagittal sections using CaBP1/CD (green) and anti-parvalbumin (PV) or anti-calretinin (CR) antibodies (magenta). Our results reveal only moderate overlap between PV-and CaBP1/CD-positive neurons in the stratum oriens and radiatum. Rather, PV-containing axons innervated CaBP1/CD-expressing CA3 neurons as some formed synaptic contact with CaBP1/CD-expressing neurons (arrowhead, Fig. 6C ).
In the CA1 region, some CaBP1/CD-expressing pyramidal cells were PV-positive (arrow, Fig. 6D -F) while some were not (arrowhead, Fig. 6D-F) . In contrast to the staining we observed in the CA regions, we detected relatively weak CaBP1/CD staining in the hilus (Fig. 4D, 5G-I) .
Although the granule cells of the dentate gyrus lacked CaBP1/CD staining, moderate labeling was observed in the hilus (Fig. 4C ), but CR-expressing hilar mossy cells (Fujise et al., 1998) were CaBP1/CD negative ( Fig. 6G-I) .
CaBP1/CD distribution varied throughout the cortical layers. Layers II/III and V/VI of the somatosensory cortices showed intense CaBP1/CD IR compared to layers I and IV (Fig. 4C-D) . In the somatosensory cortical layer V/VI, the majority of CaPB1/CD staining is concentrated predominantly in cell bodies and apical proximal dendrites ( Fig. 5D-F) . Dendritic processes of pyramidal cells extending from layers V/VI to layers II/III exhibited intense CaBP1/CD labeling (arrow, Fig. 5F ). Taken together, these results largely confirm previous descriptions of CaBP1/CD localization in neurons that may regulate learning, memory and cognitive functions.
CaBP1/CD Labeling in the Cerebellum
We detected strong CaBP1/CD labeling in cerebellar interneurons (basket and stellate cells) (arrow) as well as fibers (arrowhead) residing in the molecular layer (M) (Fig. 7A ). More than 50% of the CaBP1/CD-expressing interneurons (green) overlapped (arrow) with PV-containing neurons (magenta) in the molecular layer ( Fig. 7I-K) by double immunofluorescence staining. The purkinje layer (P) and interneurons of the granule layer (G) displayed very weak labeling ( Fig. 7A-B ).
In order to investigate the identity of these CaBP1/CD-containing cells in the purkinje layer (P), we performed double immunofluorescence analysis using CaBP1/CD and anti-CB antibodies, a Ca 2+ binding protein localized in Purkinje cell somas, dendrites, and axons (Iacopino et al., 1990; Ishikawa et al., 1995; Schwaller et al., 2002) . Purkinje cell somas (asterisk) were completely void of CaBP1/CD staining (green) as CaBP1/CD failed to colocalize with CB (magenta; Fig. 7C-E ).
Rather the puncta pattern observed in the purkinje layer (P) appeared perisomatic.
CaBP1/CD labeling was absent in Purkinje cell bodies (arrow, Fig. 7C ), but instead, localized near the axon initial segment (AIS). This specialized structure is known as the pinceau formation, a compartment shaped by basket cell axons in the molecular layer (M) wrapping around the AIS of cerebellar Purkinje cells. As high levels of Shaker-type potassium channels, K v 1.2, have been reportedly localized in these specialized structures (Iwakura et al., 2012) , the overlap between CaBP1/CD and K v 1.2 strongly suggest CaBP1/CD is localized in the cerebellar pinceau formations (arrow, Fig. 7F-H) . CaBP1/CD is the only known CaBP member confined in these presynaptic GABA-ergic compartments, which broadens our understanding on CaBP1/CD-mediated Purkinjecell regulation, and furthermore, modulation of postsynaptic Ca 2+ signaling in inhibitory neurons. -D) . Rostral (C) and mid-caudal (D) regions. S1 and S2 cortices were highly CaBP1/CD-IR compared to other cortical regions (coronal view). Very weak CaBP1/CD labeling in the striatum (CPU; D) and SNc (E-G). CaBP1/CD (green) does not colocalize with TH-expressing dopaminergic neurons (red) in the SNc, but highly localized in the SNr (coronal view). Immunofluorescence viewed under a laser scanning confocal microscope, Olympus FV1000. N = 3-6 mice (P40-100). Cerebral cortex, Ctx; cerebellum, C; hippocampus, Hc; olfactory bulb, OB; piriform cortex, Ptx; somatosensory cortices, S1; secondary somatosensory cortex, S2; caudate-putamen, CPu; substantia nigra pars compacta and pars reticulata, SNc and SNr; tyrosine hydroxylase, TH. Scale bar 1 mm in A-D, and 50 µm in E-F. 
DISCUSSION
Our studies provide a framework for understanding of CaBP1/CD-mediated Ca 2+ signaling in the murine central nervous system. Among the Ca 2+ sensor protein members, CaBP1/CD is most similar to CaM in the murine brain McCue et al., 2010; Mikhaylova et al., 2006) , but the precise role of these CaM-like proteins in neuronal Ca 2+ signaling is poorly understood. Our findings allow us formulate hypotheses regarding the functional significance of CaBP1/CD in the mouse brain, and to test these hypotheses using our CaBP1 KO mouse.
We observed heterogeneous labeling of CaBP1/CD in regions with a laminar organization.
Additionally, CaBP1/CD signals were found in both membrane and cytosol fractions with CD-S being the predominant variant expressed in the mouse brain. High RQ values of CD in the cerebral cortex and hippocampus may reflect the importance of CD in the brain functions involved in higher processing and synaptic plasticity. CD is abundantly found in the postsynaptic density of excitatory synapses formed by principal neurons Seidenbecher et al., 1998) .
Our data strongly suggest that CaBP1/CD localizes to both excitatory and inhibitory neurons, and interneurons, extending the possible roles CaBP1/CD has in the brain.
Possible Roles of CaBP1/CD in Neurons
Previous work has shown that CaBP1/CD colocalizes with Ca v 1.2 L-type Ca 2+ channels in neurons, where it may regulate L-type Ca 2+ signals Zhou et al., 2005) .
This preferential localization of CaBP1/CD in the cell soma, dendrites and dendritic spines of pyramidal cells matches previous descriptions of the localization of Ca v 1.2 channels in hippocampal and cerebral cortical pyramidal cells (Hell et al., 1993; Westenbroek et al., 1990) .
Clustered in the dendrites, dendritic spines (Davare et al., 2001; Hell et al., 1993; Obermair et al., values relative to both CaBP1-S and -L in all three regions. In addition, previous studies have shown that both CD-S and -L coimmunoprecipitate with Ca v 1.2 in rat brain . IR bands corresponding to CaBP1-S and -L could not be detected by western blotting from either rat or mouse brain. Differential intensities of IR bands (33-and 36-kDa) were exhibited in brain, especially with respect to the shorter isoform. We speculate that CD-S (the 33-kDa isoform)
is the major CaBP1/CD variant, a binding partner of a synaptic and nuclear protein, Jacob (Grover and Teyler, 1990 ).
The 33-and 36-kDa CD isoforms may not localize to the same subcellular regions in the murine brain Seidenbecher et al., 1998) . Found in both the detergent-soluble and -insoluble particulate fraction, the 33-kDa product was detected at higher levels in these subcellular fractions and in acute hippocampal slices (Seidenbecher et al., 1998) , while the 36-kDa isoform was found tightly associated with the cortical cytoskeleton Seidenbecher et al., 1998) . Their N-terminal domains of the proteins may be necessary for specific tissue types, and for their distinct subcellular localization. CaBP1-S localizes primarily to the plasma membrane and Golgi apparatus, while CaBP1-L localizes mainly to the Golgi and exhibits cytosolic localization McCue et al., 2009; McCue et al., 2010) .
Based on our results, we hypothesized that the two IR bands corresponding to CD-S and -L are isoforms translated from a single mRNA sequence, by alternative translation initiation (ATI), and not the result of differential phosphorylation. The SAPAP3 isoforms (SAPAP3α and β) are scaffolding proteins highly localized in the postsynaptic density of excitatory neurons, and products of ATI (Chua et al., 2012) . This finding led us to speculate that, similar to SAPAP3 isoforms, the CD doublet may be due to several intrinsic features within the 5'-untranslated region (5'-UTR), where short reading frames with start codons (uORF) down-regulate translation efficiency while also facilitating the synthesis of two distinct isoforms via alternative translation initiation (Chua et al., 2012) . With multiple uORFs in its 5'-UTR region, the translation efficiency of CD-L may be less favorable, as we have observed greater levels of the shorter isoform in the mouse brain.
The CD-S and CD-L may have divergent functions. Expressed in both glial and neuronal cells, TREK-2 (K 2P 10.1) belongs to the two-pore domain K + channel family (Bang et al., 2000; Gnatenco et al., 2002; Gu et al., 2002; Lesage et al., 2000) . In mammalian cells, TREK-2 exhibits two unitary conductance levels (~52 pS and ~220 pS) (Simkin et al., 2008) , where the long form of TREK-2 (~60 kDa) yields both the small and large-conductance channel, and the two shorter isoforms (~54 kDa) produce only the small-conductance channel (Honore, 2008; Simkin et al., 2008) . Similar to TREK-2 and SAPAP3 isoforms, the 33-and 36-kDa may be generated by ATI, and potentially demonstrate distinct regulatory roles.
Moderate levels of CaBP1-S and -L transcripts were observed only in the rat cerebellum by in-situ hybridization Seidenbecher et al., 1998) . CaBP1-S and -L may be important in other regions such as the retina and pituitary tissues, as CD levels were relatively low Landwehr et al., 2003) . Their tissue-specific distribution has functional implications on plasticity induction. Since the CaBP1/CD antibodies cannot discriminate CaBP1/CD variants, their distinct localization in the mouse brain remains unclear.
CaBP1/CD Localization in Inhibitory Neurons
CaBP1 and CD are located in a subset of excitatory and inhibitory neurons. Presynaptic regions of cerebellar interneurons in the molecular layer were highly CaBP1/CD-immunopositive.
Based on their localization, these interneurons are likely to be inhibitory GABA-ergic stellate and basket cells (Deisseroth et al., 2003; Seidenbecher et al., 1998) .
( McBain and Fisahn, 2001) . iLTD is induced by high-frequency stimulation of association inputs onto CA3 stratum radiatum interneurons (Laezza et al., 1999) or of mossy fiber inputs onto stratum lucidum interneurons (Toth et al., 2000) , which preferably shifts the excitation-inhibition balance towards excitation in the mossy fibre-CA3 system (McBain and Fisahn, 2001) . Despite the difficulty of characterizing these hippocampal interneurons using neurochemical markers, we are interested in studying the potential role of all variants in this novel form of synaptic plasticity using electrophysiological recordings on CaBP1 KO hippocampal slices.
CHAPTER V.
CONCLUSION
Understanding how spatially Ca 2+ signals are regulated will require a detailed knowledge of the Ca 2+ sensors involved. We observed distinct localization of CaBP1/CD in the postsynaptic somato-dendritic compartments and presynaptic regions of neurons, where these variants may mediate synaptic activity and other cellular responses. Altered distribution of CaBP1/CD-IR was reported in postmortem brains of chronic schizophrenics (Bernstein et al., 2007; McCue et al., 2010) . Changes in CaBP1/CD distribution have also been observed in kainate-induced seizures in rats, where CaBP1/CD translocates to the postsynaptic density following epileptic seizures (Bernstein et al., 2007; Smalla et al., 2003) . Unfortunately, the involvement of CaBP1/CD in the pathophysiology of these diseases, and the significance of CaBP1 and CD in neurons are not clearly understood. As the list of CaBP1/CD-mediated effectors expands, we hope to address the physiological impact of these variants in the mammalian central nervous system by utilizing the CaBP1 KO mouse.
